CD8A and neoplasm: However, further studies needed to clarify the association between PD-L1 expression and CD8+ TILs and to determine whether this combination has predictive relevance as a biomarker for selecting individual patients for treatment involving PD-1/PD-L1 blockade or for selection of certain tumor types for development.